key: cord-1005828-68g3myq3
authors: De Lorenzis, Enrico; Natalello, Gerlando; Gigante, Laura; Verardi, Lucrezia; Bosello, Silvia Laura; Gremese, Elisa
title: What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?
date: 2020-09-14
journal: Autoimmun Rev
DOI: 10.1016/j.autrev.2020.102666
sha: 2847e4aad8a91c6b3bbe95964eff1ad7209a7982
doc_id: 1005828
cord_uid: 68g3myq3

nan

Enrico De Lorenzis 1,2 , Gerlando Natalello 1 , Laura Gigante 1 , Lucrezia Verardi 1 , Silvia Laura Bosello 3 Fever, cough, dyspnoea, fatigue and myalgia are the most common symptoms and high creatinephosphokinase, and inflammatory markers (ferritin, C-reactive protein, D-dimers, interleukin-6) are associated with a poor prognosis 1 . In this regard, several pieces of evidence point toward a central role of massive and dysfunctional endothelial activation, leading to diffuse thrombotic disease, both as a specific effect of SARS-CoV-2 and as a consequence of systemic inflammation. The so-called "cytokine storm" is the production of large amounts of mediators of inflammation that can be triggered by SARS-CoV-2 infection 2 but is also described in autoimmune and autoinflammatory diseases. Vasculopathy and thrombotic manifestations seem to characterize the more aggressive cases of COVID-19 infection 3 

China: a retrospective cohort study

The Role of Cytokines including Interleukin-6 in COVID-19

induced Pneumonia and Macrophage Activation Syndrome-Like Disease

Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans

Cutaneous manifestations in COVID-19: a first perspective

Lung involvement in connective tissue diseases: a comprehensive review and a focus on rheumatoid arthritis

Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease

Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients

Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy

Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis

Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review

Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease

Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity